Last reviewed · How we verify
Spasticity caused by cerebral palsy
Approved treatments
- Xeomin · Merz Pharms
Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Spasticity caused by cerebral palsy patent landscape — cliff calendar, originator estates, attackable patents
- Spasticity caused by cerebral palsy treatment landscape brief
- Spasticity caused by cerebral palsy treatment updates RSS
Frequently asked questions about Spasticity caused by cerebral palsy
What drugs treat Spasticity caused by cerebral palsy?
Tracked treatments include Xeomin.
What is the treatment for Spasticity caused by cerebral palsy?
Standard treatment for Spasticity caused by cerebral palsy includes Xeomin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Spasticity caused by cerebral palsy patent cliff · Spasticity caused by cerebral palsy CI report
- Treatment: Xeomin · Merz Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing